|
(BS153) |
Inhibition of ADAM9 augments cardiac function after myocardial infarction |
| |
|
J. Schmidt, K. Lorenz, C. Prince, K. Guan, A. El-Armouche, E. Klapproth (Dresden, Würzburg; Lansing, US) |
|
(BS154) |
Development of Spatial and Temporal Proteomics Workflows for Pig Hearts |
| |
|
J. Jaber, L. Neuenroth, V. Ebner, S. Lehnart, C. Lenz, für die Studiengruppen: UMG, DFG, DZHK, MBExC, MPI-NAT, DKFZ (Göttingen) |
|
(BS155) |
Differential effects of betablockers carvedilol, metoprolol and bisoprolol on cardiac Kv4.3 (Ito) K+ channels |
| |
|
J. Hackbarth, A.-K. Rahm, M. E. Müller, H. Gampp, P. Lugenbiel, N. Frey, D. Thomas (Heidelberg) |
|
(BS156) |
Etripamil – a novel ion channel inhibitor to modulate atrial arrhythmopathy |
| |
|
M. Prüser, F. Wiedmann, S. Schütte, A. Paasche, L. Weirauch, N. Javorszky, N. Frey, N. Decher, C. Schmidt (Heidelberg, Marburg) |
|
(BS157) |
Effects of empagliflozin plus semaglutide on excitation contraction coupling and mitochondrial energetics in a rat model of high fat, high fructose diet-induced obesity |
| |
|
K. Ecker, J. Theisen, A. Nickel, M. Kohlhaas, V. Sequeira, C. Maack, U. Dischinger (Würzburg) |
|
(BS158) |
Effects of semaglutide in a rat model of high fat, high fructose diet-induced obesity: Focus on excitation-contraction coupling and mitochondrial function |
| |
|
J. Theisen, K. Ecker, M. Kohlhaas, A. Nickel, V. Sequeira, C. Maack, U. Dischinger (Würzburg) |
|
(BS159) |
Effects of MR33317 on human cardiac 5-HT4 receptors |
| |
|
U. Gergs, B. Hofmann, P. Dallemagne, C. Rochais, J. Neumann (Halle (Saale), Halle/Saale; Caen cedex, FR) |
|
(BS160) |
Increased vasoconstrictor and attenuated vasodilator function in mesenteric arteries of Ossabaw minipigs with a genetic predisposition to, but without the phenotype of a metabolic syndrome |
| |
|
C. Eickelmann, M. Sturek, G. Heusch, P. Kleinbongard (Essen; Indiana, US) |
